Working up to managing principal of one of the region’s leading public relations agencies, Jennifer Young Dzwonar has led global campaigns and directed international marketing for clients, with a particular interest in crisis management projects.
Dedicated to speeding up the discovery-to-implementation pipeline for life-changing medication, Nadia Nguyen Adams partners researchers and health care systems while working toward reducing hospital stays and lowering costs.
The first person to serve as chief nursing officer at the system level for St. Vincent —overseeing and unifying all 20 hospitals—Cindy Adams plays a critical role in an organization acknowledged as one of the 15 Top Health Systems in the country for 2015 and 2016 by Truven Health Analytics.
For economic development professionals, the splashy, fun side of the business is the press conferences, where local and state leaders come together to announce a company’s plans to hire hundreds or even thousands of workers. But the eco-devo experts trying to bulk up central Indiana’s economy for 21st century success know the reality of the […]
Manufacturing the drug itself typically costs pennies, but getting FDA approval certifying the drug as “safe and effective” can run upward of $2 billion.
Samuel Odle, a former hospital executive who was elected to the IPS board in 2012, served on ITT’s board of directors since 2006. The for-profit higher education company closed in September in the wake of federal sanctions.
Mark Pittman, son of late heart surgeon and developer John N. Pittman, filed a lawsuit Oct. 14 in Hamilton County against his siblings and family-owned entities involved with The Bridges, a retail development in Carmel that includes a Market District grocery store.
Shares in Taubman Centers Inc. surged Wednesday, one day after Jonathan Litt, an activist investor known for targeting real estate companies, pushed for the mall owner to cut costs or consider a sale of the company.
Democrat Evan Bayh and Republican Todd Young accused each other of being Washington insiders and putting special interests over Hoosiers during Tuesday night’s charged debate.
Eli Lilly and Co. is pledging $90 million over five years to improve access to treatment for diabetes, cancer and tuberculosis in developing countries—the latest push in its philanthropic strategy of building health care systems around the world and increasing the market for its prescription drugs.
